Daidzein combined with puerarin effectively suppresses cell proliferation by targeting the STAT3 and focal adhesion kinase (FAK) signaling pathway (STAT3/FAK), inhibiting the phosphorylation of both proteins in the endocervical adenocarcinoma cell line (BGC-823), showing selectivity toward the gastric epithelial cell line (GES-1), and reducing colony formation [30]. The gene discussed is PTK2; the disease is endocervical adenocarcinoma.